BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37835516)

  • 1. PACS-Integrated Tools for Peritumoral Edema Volumetrics Provide Additional Information to RANO-BM-Based Assessment of Lung Cancer Brain Metastases after Stereotactic Radiotherapy: A Pilot Study.
    Kaur M; Cassinelli Petersen G; Jekel L; von Reppert M; Varghese S; Dixe de Oliveira Santo I; Avesta A; Aneja S; Omuro A; Chiang V; Aboian M
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric Regression in Brain Metastases After Stereotactic Radiotherapy: Time Course, Predictors, and Significance.
    Oft D; Schmidt MA; Weissmann T; Roesch J; Mengling V; Masitho S; Bert C; Lettmaier S; Frey B; Distel LV; Fietkau R; Putz F
    Front Oncol; 2020; 10():590980. PubMed ID: 33489888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric analysis: Rethinking brain metastases response assessment.
    Ocaña-Tienda B; Pérez-Beteta J; Romero-Rosales JA; Asenjo B; Ortiz de Mendivil A; Pérez Romasanta LA; Albillo Labarra JD; Nagib F; Vidal Denis M; Luque B; Arana E; Pérez-García VM
    Neurooncol Adv; 2024; 6(1):vdad161. PubMed ID: 38187872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy.
    Hua YC; Gao DZ; Wang KY; Ding XS; Xu WR; Li YB; Shi WW; Sun SB; Li XY
    Thorac Cancer; 2023 Nov; 14(31):3133-3139. PubMed ID: 37718465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis in peritumoral volumes of brain metastases treated with stereotactic radiotherapy.
    Kim MS; Park SH; Park ES; Park JB; Kwon SC; Lyo IU; Sim HB
    J Neuroradiol; 2018 Sep; 45(5):310-315. PubMed ID: 29410152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination laser interstitial thermal therapy plus stereotactic radiotherapy increases time to progression for biopsy-proven recurrent brain metastases.
    Grabowski MM; Srinivasan ES; Vaios EJ; Sankey EW; Otvos B; Krivosheya D; Scott A; Olufawo M; Ma J; Fomchenko EI; Herndon JE; Kim AH; Chiang VL; Chen CC; Leuthardt EC; Barnett GH; Kirkpatrick JP; Mohammadi AM; Fecci PE
    Neurooncol Adv; 2022; 4(1):vdac086. PubMed ID: 35795470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSRT vs. SRS in Brain Metastases-Differences in Local Control and Radiation Necrosis-A Volumetric Study.
    Putz F; Weissmann T; Oft D; Schmidt MA; Roesch J; Siavooshhaghighi H; Filimonova I; Schmitter C; Mengling V; Bert C; Frey B; Lettmaier S; Distel LV; Semrau S; Fietkau R
    Front Oncol; 2020; 10():559193. PubMed ID: 33102223
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo Gamma Knife surgery.
    Pan HC; Sun MH; Chen CC; Chen CJ; Lee CH; Sheehan J
    J Neurosurg; 2008 Dec; 109 Suppl():90-8. PubMed ID: 19123894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large open access dataset of brain metastasis 3D segmentations on MRI with clinical and imaging information.
    Ramakrishnan D; Jekel L; Chadha S; Janas A; Moy H; Maleki N; Sala M; Kaur M; Petersen GC; Merkaj S; von Reppert M; Baid U; Bakas S; Kirsch C; Davis M; Bousabarah K; Holler W; Lin M; Westerhoff M; Aneja S; Memon F; Aboian MS
    Sci Data; 2024 Feb; 11(1):254. PubMed ID: 38424079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Large Open Access Dataset of Brain Metastasis 3D Segmentations with Clinical and Imaging Feature Information.
    Ramakrishnan D; Jekel L; Chadha S; Janas A; Moy H; Maleki N; Sala M; Kaur M; Petersen GC; Merkaj S; von Reppert M; Baid U; Bakas S; Kirsch C; Davis M; Bousabarah K; Holler W; Lin M; Westerhoff M; Aneja S; Memon F; Aboian MS
    ArXiv; 2023 Sep; ():. PubMed ID: 37744461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning.
    Jaberipour M; Soliman H; Sahgal A; Sadeghi-Naini A
    Sci Rep; 2021 Nov; 11(1):21620. PubMed ID: 34732781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response assessment and outcome of combining immunotherapy and radiosurgery for brain metastasis from malignant melanoma.
    Le Rhun E; Wolpert F; Fialek M; Devos P; Andratschke N; Reyns N; Regli L; Dummer R; Mortier L; Weller M
    ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32747372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer.
    Karlsson AT; Hjermstad MJ; Omdahl T; Aass N; Skovlund E; Hellebust TP; Johansen S; Kaasa S; Yri OE
    Acta Oncol; 2021 Aug; 60(8):1054-1060. PubMed ID: 34032536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control.
    Kanayama N; Ikawa T; Ohira S; Hirata T; Morimoto M; Ogawa K; Teshima T; Konishi K
    Cancer Med; 2022 Dec; 11(24):4806-4815. PubMed ID: 35535485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Radiotherapy for Cervical Spinal Intramedullary Metastasis and Multiple Brain Metastases: A Case Report.
    Mori Y; Kawamura T; Ohshima Y; Takeuchi A; Mori T; Ishiguchi T
    Cureus; 2016 Apr; 8(4):e590. PubMed ID: 27284497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis.
    Calderon B; Vazquez L; Belkacemi M; Pourel N
    Eur J Med Res; 2023 Jul; 28(1):233. PubMed ID: 37443046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy.
    Uto M; Ogura K; Katagiri T; Takehana K; Mizowaki T
    Radiat Oncol; 2021 Jul; 16(1):140. PubMed ID: 34321033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perilesional edema in brain metastases as predictive factor of response to systemic therapy in non-small cell lung cancer patients: a preliminary study.
    Alemany M; Domènech M; Argyriou AA; Vilariño N; Majós C; Naval-Baudin P; Lucas A; Palmero R; Simó M; Nadal E; Bruna J
    Ann Transl Med; 2021 Apr; 9(8):648. PubMed ID: 33987346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.